Cyclodextrin and antibody-drug conjugate formulations
US10391181B2 · kind B2 · utility
1Cited by
6References
1Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 30, 2018 |
| Grant date | Aug 27, 2019 |
| Priority date | — |
| Expiry date | Apr 30, 2038 |
Classification
- Technology area (CPC B)Performing Operations; Transporting
- CPC primaryB01D2315/16
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed are formulations, including both liquid and lyophilized formulations, comprising a benzodiazepine antibody-drug conjugate (ADC) and a cyclodextrin. Also disclosed are methods of purifying mixtures comprising benzodiazepine antibody-drug conjugates and process drug-related impurities.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.